StockStory

Articles in “HCAT”

Health Catalyst (NASDAQ:HCAT) Surprises With Q3 Sales Cover Image
NASDAQ HCAT Earnings
Health Catalyst (NASDAQ:HCAT) Surprises With Q3 Sales

Jabin Bastian 2022/11/08 9:09pm

Healthcare software provider Health Catalyst (NASDAQ:HCAT) reported results ahead of analyst expectations in the Q3 FY2022 quarter, with revenue up 10.7% year on year to $68.3 million. The company expects that next quarter's revenue would be around $67.9 million, which is the midpoint of the guidance range. That was in roughly line with analyst expectations. Health Catalyst made a GAAP loss of $45.7 million, down on its loss of $40 million, in the same quarter last year. ... Continue Reading Continue Reading
Health Catalyst (NASDAQ:HCAT) Surprises With Q2 Sales But Stock Drops Cover Image
NASDAQ HCAT Earnings
Health Catalyst (NASDAQ:HCAT) Surprises With Q2 Sales But Stock Drops

Jabin Bastian 2022/08/04 8:45pm

Healthcare software provider Health Catalyst (NASDAQ:HCAT) beat analyst expectations in Q2 FY2022 quarter, with revenue up 18.4% year on year to $70.6 million. However, guidance for the next quarter was less impressive, coming in at $66.8 million at the midpoint, being 10.4% below analyst estimates. Health Catalyst made a GAAP loss of $33.4 million, improving on its loss of $35.8 million, in the same quarter last year.... Continue Reading Continue Reading
Health Catalyst (NASDAQ:HCAT) Surprises With Q1 Sales But Guidance Underwhelms Cover Image
NASDAQ HCAT Earnings
Health Catalyst (NASDAQ:HCAT) Surprises With Q1 Sales But Guidance Underwhelms

Radek Strnad 2022/05/10 8:15pm

Healthcare software provider Health Catalyst (NASDAQ:HCAT) reported Q1 FY2022 results that beat analyst expectations, with revenue up 21.9% year on year to $68 million. However, guidance for the next quarter was less impressive, coming in at $69.5 million at the midpoint, being 2% below analyst estimates. Health Catalyst made a GAAP loss of $22.4 million, improving on its loss of $28.3 million, in the same quarter last year.... Continue Reading Continue Reading
Health Catalyst's (NASDAQ:HCAT) Q4 Sales Top Estimates But Growth To Slow Down Next Year Cover Image
NASDAQ HCAT Earnings
Health Catalyst's (NASDAQ:HCAT) Q4 Sales Top Estimates But Growth To Slow Down Next Year

Adam Hejl 2022/03/01 9:16pm

Healthcare software provider Health Catalyst (NASDAQ:HCAT) reported Q4 FY2021 results beating Wall St's expectations, with revenue up 21.4% year on year to $64.7 million. However, guidance for the next quarter was less impressive, coming in at $65.5 million at the midpoint, being 3.68% below analyst estimates. Health Catalyst made a GAAP loss of $48.9 million, down on its loss of $43 million, in the same quarter last year. ... Continue Reading Continue Reading
Health Catalyst (NASDAQ:HCAT) Q3 Sales Beat Estimates But Gross Margin Drops Cover Image
NASDAQ HCAT Earnings
Health Catalyst (NASDAQ:HCAT) Q3 Sales Beat Estimates But Gross Margin Drops

Jabin Bastian 2021/11/09 9:12pm

Healthcare software provider Health Catalyst (NASDAQ:HCAT) announced better-than-expected results in the Q3 FY2021 quarter, with revenue up 30.8% year on year to $61.7 million. The company expects that next quarter's revenue would be around $62.9 million, which is the midpoint of the guidance range. That was in roughly line with analyst expectations. Health Catalyst made a GAAP loss of $40 million, down on its loss of $27.3 million, in the same quarter last year. ... Continue Reading Continue Reading